Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)

INTRODUCTION: Immunohistochemistry of primary breast cancer is routinely used to guide changes in therapy at the time of relapse. Retrospective reviews suggest that the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor type 2 (HER2) receptor may differ bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Alastair M, Jordan, Lee B, Quinlan, Philip, Anderson, Elizabeth, Skene, Anthony, Dewar, John A, Purdie, Colin A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046433/
https://www.ncbi.nlm.nih.gov/pubmed/21059212
http://dx.doi.org/10.1186/bcr2771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046433/
https://www.ncbi.nlm.nih.gov/pubmed/21059212
http://dx.doi.org/10.1186/bcr2771

Ejemplares similares